Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 1, 1997, Pages 20-23

  Weiss, I ^a   Gorodnitzky, Z ^b   Korenman, Z ^b   Yagupsky, P ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Public Health Laboratories   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; M PROTEIN; MACROLIDE; PENICILLIN G; TETRACYCLINE; VIRUS T ANTIGEN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; CLINDAMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; ISRAEL; PENICILLINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0031045624     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01575115     Document Type: Article

References (15)

1. Stevens DA: Invasive group A streptococcus infections. Clinical Infectious Diseases 1992, 14: 2-13.
2. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, Holm SE, Jahkola M, Katila ML, Klaukka T, Kontiainen S, Liimatainen O, Oinonen S, Passi-Metsomaa L, Huovinen P: Resistance to erythromycin in group A streptococci: New England Journal of Medicine 1992, 326: 292-297.
3. Hooton TM: A comparison of azithromycin and penicillin for the treatment of streptococcal pharyngitis. American Journal of Medicine 1991, 91, Supplement 3A: 235-238.
4. Bachland RT Jr: A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis. Journal of Antimicrobial Chemotherapy 1991, 27, Supplement A: 75-82.
5. Maruyama S, Yoshioka H, Fojita K, Takimoto M, Satake Y: Sensitivity of group A streptococci to antibiotics. American Journal of Diseases of Children 1979, 133: 1143-1145.
6. Gerber MA: Antibiotic resistance in group A streptococci. Pediatric Clinics of North America 1995, 42: 539-551.
7. Seppala H, Klaukka T, Lethonen R, Nenonen E, Huovinen P, and the Finnish Group for Antimicrobial Resistance: Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clinical Infectious Diseases 1995, 21: 1378-1385.
8. Rudensky B, Isaacson M, Beck A, Greenfield J: Increase in frequency of serious group A streptococcal infections. Israel Journal of the Medical Sciences 1992, 28: 752-753.
9. Moses AE, Mevorach D, Rahav G, Sacks T, Simhon A, Shapiro M: Group A streptococcus bacteremia at the Hadassah Medical Center in Jerusalem. Clinical Infectious Diseases 1995, 20: 1393-1395.
10. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Vol. 15, No. 14, Wayne PA, 1995.
11. Bergner-Rabinowitz S, Ferne M: Type distribution of β-hemolytic streptococci in Israel: a 10-year study. Journal of Infectious Diseases 1978, 138: 152-159.
12. Schwartz B, Faclam RR, Breiman RF: Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990, 336: 1167-1171.
13. Johnson DR, Stevens DL, Kaplan EL: Epidemiologie analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. Journal of Infectious Diseases 1992, 166: 374-382.
14. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, Schlievert PM: Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992, 339: 518-521.
15. Stevens DL, Gibbons AE, Bergstrom R, Winn V: The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. Journal of Infectious Diseases 1988, 158: 23-28.